1997
DOI: 10.1097/00006982-199711000-00007
|View full text |Cite
|
Sign up to set email alerts
|

Experimental studies with perfluoro-octane for hemostasis during vitreoretinal surgery

Abstract: Perfluoro-octane may be used to control bleeding during vitreoretinal surgery. A direct effect on the clotting cascade could not be demonstrated.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0
3

Year Published

2004
2004
2012
2012

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 0 publications
0
0
0
3
Order By: Relevance
“…Outros usos incluem casos complicados de descolamento de retina (3)(4) , vitreoretinopatia diabética (5) e controle de hemorragias vítreas transoperatórias (6) . Os PFCLs são eficientes em manter a retina colada, em descolamentos de retina induzidos experimentalmente (7) .…”
Section: Introductionunclassified
“…Outros usos incluem casos complicados de descolamento de retina (3)(4) , vitreoretinopatia diabética (5) e controle de hemorragias vítreas transoperatórias (6) . Os PFCLs são eficientes em manter a retina colada, em descolamentos de retina induzidos experimentalmente (7) .…”
Section: Introductionunclassified
“…Ââåäåíèå. Èíòðàîïåðàöèîííîå êðîâîòå÷åíèå ñ÷èòàåòñÿ îäíèì èç îñíîâíûõ îñëîaeíåíèé çàäíåé çàêðûòîé âèòðýêòîìèè ó áîëüíûõ ïðîëèôåðàòèâíîé äèàáåòè÷åñêîé ðåòèíîïàòèåé, âíóòðèãëàçíûìè íîâîîáðàçîâàíèÿìè (àíãèîìàòîç Ãèïïåëÿ-Ëèíäàó, ìåëàíîìà ñîñóäèñòîé îáîëî÷êè), êîòîðîå ñíèaeàåò ýôôåêòèâíîñòü õèðóðãèè, â ðÿäå ñëó÷àåâ ìîaeåò áûòü íåêîíòðîëèðóåìûì è ïðèâîäèòü ê òÿaeåëûì ïîñëåäñòâèÿì [1][2][3][4]. Êðîìå òîãî, èíòðàîïåðàöèîííîå êðîâîòå÷åíèå âî âðåìÿ âèòðýêòîìèè óâåëè÷èâàåò ðèñê ðàçâèòèÿ ãåìîôòàëüìîâ â ðàííåì ïîñëåîïåðàöèîííîì ïåðèîäå, ÷òî ïîä÷åðêèâàåò íåîáõîäèìîñòü òùàòåëüíîãî èíòðàîïåðàöèîííîãî ãåìîñòàçà [5].…”
unclassified
“…Íåñìîòðÿ íà çíà÷èòåëüíûå óñèëèÿ, íàïðàâëåííûå â òå÷åíèå ïîñëåäíèõ äåñÿòèëåòèé íà èçó÷åíèå ïàòîãåíåçà âîçðàñòíîé êàòàðàêòû è ðàçðàáîòêó íîâûõ ñðåäñòâ åå êîíñåðâàòèâíîãî ëå÷åíèÿ è ïðîôèëàêòèêè, ðàñïðîñòðàíåíèå ýòîãî çàáîëåâàíèÿ ïðîäîëaeàåò âîçðàñòàòü.  ýòîé ñâÿçè àêòóàëüíûì îñòàåòñÿ ïîèñê íîâûõ è óñîâåðøåíñòâîâàíèå ñóùåñòâóþùèõ ñïîñîáîâ ìåäèêàìåíòîçíîé ïðîôèëàêòèêè è ëå÷åíèÿ êàòàðàêòû íà ðàííåé ñòàäèè åå ðàçâèòèÿ [2,10,20].…”
unclassified